Carlos Caulı́n

5.0k total citations · 1 hit paper
41 papers, 2.3k citations indexed

About

Carlos Caulı́n is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, Carlos Caulı́n has authored 41 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 13 papers in Molecular Biology and 9 papers in Surgery. Recurrent topics in Carlos Caulı́n's work include Cancer-related Molecular Pathways (16 papers), Skin and Cellular Biology Research (6 papers) and Salivary Gland Tumors Diagnosis and Treatment (5 papers). Carlos Caulı́n is often cited by papers focused on Cancer-related Molecular Pathways (16 papers), Skin and Cellular Biology Research (6 papers) and Salivary Gland Tumors Diagnosis and Treatment (5 papers). Carlos Caulı́n collaborates with scholars based in United States, China and France. Carlos Caulı́n's co-authors include Robert G. Oshima, Guy S. Salvesen, Adel K. El‐Naggar, Thomas M. Magin, Carl F. Ware, Yoshitsugu Mitani, Randal S. Weber, Pulivarthi H. Rao, Dennis R. Roop and Scott M. Lippman and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Carlos Caulı́n

39 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Caspase Cleavage of Keratin 18 and Reorganization of Intermediate Filaments during Epithelial Cell Apoptosis

1997 522 citations Carlos Caulı́n et al. profile →

Peers

Countries citing papers authored by Carlos Caulı́n

Since Specialization

Citations

This map shows the geographic impact of Carlos Caulı́n's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Caulı́n with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Caulı́n more than expected).

Fields of papers citing papers by Carlos Caulı́n

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos Caulı́n. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Caulı́n. The network helps show where Carlos Caulı́n may publish in the future.

Co-authorship network of co-authors of Carlos Caulı́n

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos Caulı́n. A scholar is included among the top collaborators of Carlos Caulı́n based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos Caulı́n. Carlos Caulı́n is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Impact of absent in melanoma 2 on head and neck squamous cell carcinoma development 2025 ·The Journal of Immunology ·(unknown), (unknown), (unknown), (unknown), Carlos Caulı́n, Justin E. Wilson	0
2	Randomized Phase II Trial of Ficlatuzumab With or Without Cetuximab in Pan-Refractory, Recurrent/Metastatic Head and Neck Cancer 2023 ·Journal of Clinical Oncology ·Julie E. Bauman, Nabil F. Saba, Denise J. Roe, Jessica R. Bauman, John M. Kaczmar, Aarti Bhatia, Jameel Muzaffar, Ricklie Julian, Steven Wang, (unknown), (unknown), Conor Steuer, (unknown), Barbara Burtness, Sara Centuori, Carlos Caulı́n, Robert J. Klein, Kathylynn Saboda, (unknown), Christine H. Chung	25
3	Female Immunity Protects from Cutaneous Squamous Cell Carcinoma 2021 ·Clinical Cancer Research ·Timothy Budden, Caroline Gaudy‐Marqueste, Sarah Craig, Yuan Hu, Charles H. Earnshaw, (unknown), (unknown), Victoria Akhras, Patrick Shenjere, Ruth Green, Lynne Jamieson, John T. Lear, (unknown), Carlos Caulı́n, Deemesh Oudit, Simon J. Furney, Amaya Virós	11
4	Overexpression of MYB in the Skin Induces Alopecia and Epidermal Hyperplasia 2019 ·Journal of Investigative Dermatology ·Yuan Hu, (unknown), Jiang Chen, Carlos Caulı́n	6
5	PD-1 Blockade Prevents the Development and Progression of Carcinogen-Induced Oral Premalignant Lesions 2017 ·Cancer Prevention Research ·Jin Wang, Tongxin Xie, Bingbing Wang, William N. William, John V. Heymach, Adel K. El‐Naggar, Jeffrey N. Myers, Carlos Caulı́n	58
6	Novel MYBL1 Gene Rearrangements with Recurrent MYBL1–NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations 2015 ·Clinical Cancer Research ·Yoshitsugu Mitani, Bin Liu, Pulivarthi H. Rao, Vishnupriya J. Borra, Mark Zafereo, Randal S. Weber, Merrill S. Kies, Guillermina Lozano, P. Andrew Futreal, Carlos Caulı́n, Adel K. El‐Naggar	154
7	Wee-1 Kinase Inhibition Sensitizes High-Risk HPV+ HNSCC to Apoptosis Accompanied by Downregulation of MCl-1 and XIAP Antiapoptotic Proteins 2015 ·Clinical Cancer Research ·Noriaki Tanaka, Ameeta A. Patel, Jiping Wang, Mitchell J. Frederick, Nene N. Kalu, Mei Zhao, Alison L. Fitzgerald, Tongxin Xie, Natalie L. Silver, Carlos Caulı́n, Ge Zhou, Heath D. Skinner, Faye M. Johnson, Jeffrey N. Myers, Abdullah A. Osman	46
8	Alterations Associated with Androgen Receptor Gene Activation in Salivary Duct Carcinoma of Both Sexes: Potential Therapeutic Ramifications 2014 ·Clinical Cancer Research ·Yoshitsugu Mitani, Pulivarthi H. Rao, Sankar N. Maity, Yu-Chen Lee, Renata Ferrarotto, (unknown), Lisa Licitra, Scott M. Lippman, Merrill S. Kies, Randal S. Weber, Carlos Caulı́n, Sue-Hwa Lin, Adel K. El‐Naggar	56
9	Wee-1 Kinase Inhibition Overcomes Cisplatin Resistance Associated with High-Risk TP53 Mutations in Head and Neck Cancer through Mitotic Arrest Followed by Senescence 2014 ·Molecular Cancer Therapeutics ·Abdullah A. Osman, Marcus M. Monroe, Marcus V. Ortega Alves, Ameeta A. Patel, Panagiotis Katsonis, Alison L. Fitzgerald, David M. Neskey, Mitchell J. Frederick, Sang Hyeok Woo, Carlos Caulı́n, (unknown), Thomas O. McDonald, Marek Kimmel, Raymond E. Meyn, Olivier Lichtarge, Jeffrey N. Myers	88
10	Loss of epithelial p53 and αv integrin cooperate through Akt to induce squamous cell carcinoma yet prevent remodeling of the tumor microenvironment 2014 ·Oncogene ·Aaron Savar, Sergio Acı́n, (unknown), Tarek El-Sawy, (unknown), Zhiyang Li, Bita Esmaeli, Adam Lacy‐Hulbert, Adel K. El‐Naggar, Joseph H. McCarty, Carlos Caulı́n	17
11	Differential regulation of the REGγ–proteasome pathway by p53/TGF-β signalling and mutant p53 in cancer cells 2013 ·Nature Communications ·Amjad Ali, Zhuo Wang, Junjiang Fu, Ji Lei, Jiang Liu, Lei Li, Hui Wang, Jiwu Chen, Carlos Caulı́n, Jeffrey N. Myers, Pei Zhang, Jianru Xiao, Bianhong Zhang, Xiaotao Li	87
12	Detailed Genome-Wide SNP Analysis of Major Salivary Carcinomas Localizes Subtype-Specific Chromosome Sites and Oncogenes of Potential Clinical Significance 2013 ·American Journal Of Pathology ·Li Zhang, Yoshitsugu Mitani, Carlos Caulı́n, Pulivarthi H. Rao, Merrill S. Kies, Pierre Saintigny, Nianxiang Zhang, Randal S. Weber, Scott M. Lippman, Adel K. El‐Naggar	17
13	Novel Chromosomal Rearrangements and Break Points at the t(6;9) in Salivary Adenoid Cystic Carcinoma: Association with MYB – NFIB Chimeric Fusion, MYB Expression, and Clinical Outcome 2011 ·Clinical Cancer Research ·Yoshitsugu Mitani, Pulivarthi H. Rao, P. Andrew Futreal, Dianna Roberts, Philip J. Stephens, Yi-Jue Zhao, Li Zhang, (unknown), Randal S. Weber, Scott M. Lippman, Carlos Caulı́n, Adel K. El‐Naggar	116
14	Disruptive TP53 Mutation Is Associated with Aggressive Disease Characteristics in an Orthotopic Murine Model of Oral Tongue Cancer 2011 ·Clinical Cancer Research ·Daisuke Sano, Tong-Xin Xie, Thomas J. Ow, Mei Zhao, Curtis R. Pickering, Ge Zhou, Vlad C. Sandulache, David A. Wheeler, Richard A. Gibbs, Carlos Caulı́n, Jeffrey N. Myers	87
15	Expression and Regulation of the ΔN and TAp63 Isoforms in Salivary Gland Tumorigenesis 2011 ·American Journal Of Pathology ·Yoshitsugu Mitani, Jie Li, Randal S. Weber, (unknown), Elsa R. Flores, Carlos Caulı́n, Adel K. El‐Naggar	15
16	Comprehensive Analysis of the MYB-NFIB Gene Fusion in Salivary Adenoid Cystic Carcinoma: Incidence, Variability, and Clinicopathologic Significance 2010 ·Clinical Cancer Research ·Yoshitsugu Mitani, Jie Li, Pulivarthi H. Rao, Yi-Jue Zhao, Diana Bell, Scott M. Lippman, Randal S. Weber, Carlos Caulı́n, Adel K. El‐Naggar	219
17	A Genetic Variant of Aurora Kinase A Promotes Genomic Instability Leading to Highly Malignant Skin Tumors 2009 ·Cancer Research ·Enrique C. Torchia, Yiyun Chen, (unknown), Hiroshi Katayama, James A. J. Fitzpatrick, William R. Brinkley, Carlos Caulı́n, Subrata Sen, Dennis R. Roop	29
18	An inducible mouse model for skin cancer reveals distinct roles for gain- and loss-of-function p53 mutations 2007 ·Journal of Clinical Investigation ·Carlos Caulı́n, Thao Nguyen, (unknown), Thea M. Goepfert, B. R. Brinkley, Wei-Wen Cai, Guillermina Lozano, Dennis R. Roop	109
19	Suppression of the metastatic phenotype of a mouse skin carcinoma cell line independent of E-cadherin expression and correlated with reduced levels of Ha-ras oncogene products 1996 ·Molecular Carcinogenesis ·Carlos Caulı́n, Lluís López-Barcons, (unknown), Pilar Navarro, Encarnación Lozano, Isabel Rodrigo, Carlos Gamallo, Amparo Cano, Àngels Fabra, Miguel Quintanilla	6
20	Effect of psychological stress on gastric potential difference in man. 1991 ·PubMed ·Jean‐François Bergmann, Carlos Caulı́n, Jean Genève, Guy G. Simoneau, (unknown)	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact